ESC Premium Access

Apixaban for treatment of embolic stroke of undetermined source (ATTICUS) randomized trial - Update of patient characteristics and study timeline after interim analysis

Presentation

About the speaker

Doctor Sven Poli

Eberhard-Karls University of Tubingen, Tuebingen (Germany)
1 presentation
0 follower

4 more presentations in this session

Capacities of atrial fibrillation detection after stroke : a French nationwide survey

Speaker: Doctor C. Guidoux (Paris, FR)

Thumbnail

Impact of excessive supraventricular ectopic activity detected in the acute phase of stroke or TIA on AF detection and death within 24 months - Results of the prospective MonDAFIS study

Speaker: Professor K. Haeusler (Wurzburg, DE)

Thumbnail

Similarities and differences in risk factors for retinal artery occlusion and stroke.

Speaker: Ms M. Oerskov (Aalborg, DK)

Thumbnail

Patient characteristics and clinical outcomes of type 2 myocardial infarction in patients with acute ischemic stroke in the united states

Speaker: Mr R. Ariss (Toledo, US)

Thumbnail

Access the full session

Novel insight into thromboembolic stroke and transient ischemic attack

Speakers: Doctor S. Poli, Doctor C. Guidoux, Professor K. Haeusler, Ms M. Oerskov, Mr R. Ariss
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

A curated selection of highlights

24 October 2021

ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

27 August 2021

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

This platform is supported by

logo Novo Nordisk